Allium Medical promotes CFO to CEO
This article was originally published in Clinica
Allium Medical (Caesarea, Israel), a developer and manufacturer of removable stents specially designed for the urinary and gastro-intestinal tract (see Medtech Ventures No 18 in Clinica No 1299) has promoted Limor Domnitz Gishri to CEO. Her successor as CFO is yet to be decided. Formerly CFO and vice-president of business, Ms Domnitz Gishri will now lead the company’s strategic growth plans. Her background is in law and accounting, where she specialised in advanced technologies and biotech. She currently combines her business responsibilities with lecturing in business and accounting at Tel Aviv University and College. Allium says Ms Domnitz Gishri has helped transform the company over two years from an R&D firm to a sales and distribution company.